275 Ill. App. 3d 593 - Proctor v. Davis’s Empirical Analysis
1995
Citation profile
1 federal appellate · 6 state decisions
Relationships
Relies on 79 Ill. 2d 564 - People v. Carlson · 117 Ill. 2d 507 - Kirk v. Michael Reese Hospital & Medical Center · 64 Ill. 2d 543 - Lawson v. G. D. Searle & Co. · 17 Cal. App. 3d 958 - Carmichael v. Reitz · McEwen v. Ortho Pharmaceutical Corporation
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 8 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“"I know of no way of giving a definite answer *** as to why the eye becomes red after the subconjunctival use of Depo-Medrol. I do think that it should be pointed out, however, that it has never been recommended that Depo-Medrol be used this way. Our recommendations for Depo-Medrol is that the injection be given deep intramuscularly or if used for intralesional treatment of the skin, that the injections be kept as small as possible. It seems to me that 1 cc. of Depo-Medrol subconjunctivally is a rather large dose to place in this area. When this amount is given subcutaneously in other areas of the body, it can occasionally cause tissue atrophy. I would think that our best recommendation *** would be that at this dosage level of Depo-Medrol, *** the medication [should be given] intramuscularly, as probably the predominant steroid effect is going to be a systemic effect anyway. This preparation is a suspension and not a solution, and it may well be that the crystalline material in the area of such a sensitive tissue as a subconjunctiva is the cause in itself for the redness.” (Emphasis added.)”
1 later decision quote this exact passage · from the concurrence“"Thank you very much for *** your interest in Depo-Medrol for subconjunctival injection in the treatment of uveitis. We do not have any reports concerning this use for the preparation and we would very much like for you to evaluate it in this way.” (Emphasis added.)”
1 later decision quote this exact passage · from the concurrence“"Maximum local response may be expected with only minimal or no systemic steroid effects. A voluminous mass of reports testifies to the efficacy and safety of this report in general medicine and in surgery!!]” (Emphasis added.)”
1 later decision quote this exact passage · from the concurrence
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.